|
C17ORF75 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.79549955301195E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
6.642800E-01 |
| Stage1-vs-Stage3 |
3.35179999999546E-06 |
| Stage1-vs-Stage4 |
6.130400E-02 |
| Stage2-vs-Stage3 |
4.441800E-03 |
| Stage2-vs-Stage4 |
9.854100E-02 |
| Stage3-vs-Stage4 |
1.026350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.1398999522072E-09 |
| Normal-vs-Asian |
7.442500E-02 |
| Caucasian-vs-AfricanAmerican |
1.163860E-02 |
| Caucasian-vs-Asian |
2.020500E-02 |
| AfricanAmerican-vs-Asian |
2.599800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.084400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.09732231581938E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
9.63051860480846E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.586400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.055580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.649000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.931550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.481350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.012200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.741230E-03 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
1.111210E-01 |
| Grade 1-vs-Grade 3 |
2.290300E-02 |
| Grade 1-vs-Grade 4 |
2.100700E-03 |
| Grade 2-vs-Grade 3 |
1.684420E-01 |
| Grade 2-vs-Grade 4 |
2.341500E-03 |
| Grade 3-vs-Grade 4 |
2.435500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
2.220400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
6.17910000944022E-09 |
| N0-vs-N1 |
3.035000E-01 |
|
|
